Emulsion Technology in Nuclear Medicine: Targeted Radionuclide Therapies, Radiosensitizers, and Imaging Agents

References

• Kramer-Marek G, Capala J. The role of nuclear medicine in modern therapy of cancer. Tumor Biol. 2012;33(3):629–640. doi:10.1007/s13277-012-0373-8
   PubMedGoogle Scholar
• Aboagye EO, Barwick TD, Haberkorn U. Radiotheranostics in oncology: making precision medicine possible. CA Cancer J Clin. 2023;73(3):255–274. doi:10.3322/caac.21768
   PubMed Web of Science ®Google Scholar
• Schofield R, Menezes L, Underwood SR. Nuclear cardiology: state of the art. Heart. 2021. doi:10.1136/heartjnl-2019-315628
   Google Scholar
• Anagnostopoulos C, Underwood R. Nuclear cardiology. Clin Med. 2012;12(4):373–377. doi:10.7861/clinmedicine.12-4-373
   PubMed Web of Science ®Google Scholar
• Wang J, Jin C, Zhou J, et al. PET molecular imaging for pathophysiological visualization in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2023;50(3):765–783. doi:10.1007/s00259-022-05999-z
   PubMed Web of Science ®Google Scholar
• Khalatbari H, Shulkin BL, Parisi MT. Emerging trends in radionuclide imaging of infection and inflammation in pediatrics: focus on FDG PET/CT and immune reactivity. Semin Nucl Med. 2023;53(1):18–36. doi:10.1053/j.semnuclmed.2022.10.002
   PubMed Web of Science ®Google Scholar
• Oh JS. Nuclear medicine physics: review of advanced technology. Prog Med Phys. 2020;31(3):81–98. doi:10.14316/pmp.2020.31.3.81
   Google Scholar
• Kaushik D, Jangra P, Verma R, et al. Radiopharmaceuticals: an insight into the latest advances in medical uses and regulatory perspectives. J Biosci. 2021;2021:46.
   Google Scholar
• Ramnaraign B, Sartor O. PSMA-targeted radiopharmaceuticals in prostate cancer: current data and new trials. Oncologist. 2023;28(5):392–401. doi:10.1093/oncolo/oyac279
   PubMed Web of Science ®Google Scholar
• Pallares RM, Abergel RJ. Development of radiopharmaceuticals for targeted alpha therapy: where do we stand? Front Med. 2022;9:1020188. doi:10.3389/fmed.2022.1020188
   Web of Science ®Google Scholar
• Handkiewicz-Junak D, Poeppel TD, Bodei L, et al. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides. Eur J Nucl Med Mol Imaging. 2018;45(5):846–859. doi:10.1007/s00259-018-3947-x
   PubMed Web of Science ®Google Scholar
• Goldsmith SJ. Targeted radionuclide therapy: a historical and personal review. Semin Nucl Med. 2020;50(1):87–97. doi:10.1053/j.semnuclmed.2019.07.006
   PubMed Web of Science ®Google Scholar
• Pellico J, Gawne PJ, de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev. 2021;50(5):3355–3423. doi:10.1039/D0CS00384K
   PubMed Web of Science ®Google Scholar
• Wu S, Helal-Neto E, Matos APDS, et al. Radioactive polymeric nanoparticles for biomedical application. Drug Deliv. 2020;27(1):1544–1561. doi:10.1080/10717544.2020.1837296
   PubMed Web of Science ®Google Scholar
• Nehoff H, Parayath NN, Domanovitch L, Taurin S, Greish K. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int J Nanomedicine. 2014;9(1):2539–2555. doi:10.2147/IJN.S47129
   PubMedGoogle Scholar
• Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol. 2013;24(6):1159–1166. doi:10.1016/j.copbio.2013.02.020
   PubMed Web of Science ®Google Scholar
• Lepareur N, Lacœuille F, Bouvry C, et al. Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives. Front Med. 2019;6:132. doi:10.3389/fmed.2019.00132
   Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–151. doi:10.1016/j.addr.2010.04.009
   PubMed Web of Science ®Google Scholar
• Lee W, Il An G, Park H, et al. Imaging Strategy that achieves ultrahigh contrast by utilizing differential esterase activity in organs: application in early detection of pancreatic cancer. ACS Nano. 2021;15(11):17348–17360. doi:10.1021/acsnano.1c05165
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced mode of drug delivery system. Biotech. 2015;5(2):123–127. doi:10.1007/s13205-014-0214-0
   Google Scholar
• Díez-Villares S, Pellico J, Gómez-Lado N, et al. Biodistribution of (68/67)Ga-radiolabeled sphingolipid nanoemulsions by PET and SPECT Imaging. Int J Nanomedicine. 2021;16:5923–5935. doi:10.2147/IJN.S316767
   PubMed Web of Science ®Google Scholar
• Kim H, Lee SK, Kim YM, et al. Fluorescent iodized emulsion for pre- and intraoperative sentinel lymph node imaging: validation in a preclinical model. Radiology. 2014;275(1):196–204. doi:10.1148/radiol.14141159
   PubMed Web of Science ®Google Scholar
• Holman R, Lorton O, Guillemin PC, Desgranges S, Contino-Pépin C, Salomir R. Perfluorocarbon emulsion contrast agents: a mini review. Front Chem. 2021;9:810029. doi:10.3389/fchem.2021.810029
   PubMed Web of Science ®Google Scholar
• Sánchez-López E, Guerra M, Dias-Ferreira J, et al. Current applications of nanoemulsions in cancer therapeutics. Nanomater. 2019;9(6). doi:10.3390/nano9060821
   Web of Science ®Google Scholar
• Zhang T, Li M, Yang R, et al. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer. Int J Pharm. 2018;546(1–2):61–69. doi:10.1016/j.ijpharm.2018.05.032
   PubMedGoogle Scholar
• Qiu Z-H, Zhang -W-W, Zhang -H-H, Jiao G-H. Brucea javanica oil emulsion improves the effect of radiotherapy on esophageal cancer cells by inhibiting cyclin D1-CDK4/6 axis. World J Gastroenterol. 2019;25(20):2463–2472. doi:10.3748/wjg.v25.i20.2463
   PubMed Web of Science ®Google Scholar
• Jain S, Winuprasith T, Suphantharika M. Design and synthesis of modified and resistant starch-based oil-in-water emulsions. Food Hydrocoll. 2019;89:153–162. doi:10.1016/j.foodhyd.2018.10.036
   Web of Science ®Google Scholar
• Karthik P, Ezhilarasi PN, Anandharamakrishnan C. Challenges associated in stability of food grade nanoemulsions. Crit Rev Food Sci Nutr. 2017;57(7):1435–1450. doi:10.1080/10408398.2015.1006767
   PubMed Web of Science ®Google Scholar
• Zhu Y, Ye J, Zhang Q. Self-emulsifying drug delivery system improve oral bioavailability: role of excipients and physico-chemical characterization. Pharm Nanotechnol. 2020;8(4):290–301. doi:10.2174/2211738508666200811104240
   PubMedGoogle Scholar
• Wilson RJ, Li Y, Yang G, Zhao C-X. Nanoemulsions for drug delivery. Particuology. 2022;64:85–97. doi:10.1016/j.partic.2021.05.009
   Web of Science ®Google Scholar
• Salawi A. Self-emulsifying drug delivery systems: a novel approach to deliver drugs. Drug Deliv. 2022;29(1):1811–1823. doi:10.1080/10717544.2022.2083724
   PubMed Web of Science ®Google Scholar
• Dragulska SA, Chen Y, Wlodarczyk MT, et al. Tripeptide-stabilized oil-in-water nanoemulsion of an oleic acids–platinum (II) conjugate as an anticancer nanomedicine. Bioconjug Chem. 2018;29(8):2514–2519.
   PubMed Web of Science ®Google Scholar
• Patel NR, Piroyan A, Ganta S, et al. In vitro and in vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers. Cancer Biol Ther. 2018;19(7):554–564. doi:10.1080/15384047.2017.1395118
   PubMed Web of Science ®Google Scholar
• Chen L, Ao F, Ge X, Shen W. Food-grade pickering emulsions: preparation, stabilization and applications. Molecules. 2020;25(14). doi:10.3390/molecules25143202
   Web of Science ®Google Scholar
• Zhang W, Fu L, Yang H. Micrometer-scale mixing with pickering emulsions: biphasic reactions without stirring. Chem Sus Chem. 2014;7(2):391–396. doi:10.1002/cssc.201301001
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhu J, Cheng Y, Huang Q. Recent advances in pickering double emulsions and potential applications in functional foods: a perspective paper. Foods. 2023;12(5). doi:10.3390/foods12050992
   Web of Science ®Google Scholar
• Ganta S, Singh A, Patel NR, et al. Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer. Pharm Res. 2014;31(9):2490–2502. doi:10.1007/s11095-014-1345-z
   PubMed Web of Science ®Google Scholar
• Natesan S, Sugumaran A, Ponnusamy C, Thiagarajan V, Palanichamy R, Kandasamy R. Chitosan stabilized camptothecin nanoemulsions: development, evaluation and biodistribution in preclinical breast cancer animal mode. Int J Biol Macromol. 2017;104:1846–1852.
   PubMed Web of Science ®Google Scholar
• Qadir A, Faiyazuddin MD, Talib Hussain MD, Alshammari TM, Shakeel F. Critical steps and energetics involved in a successful development of a stable nanoemulsion. J Mol Liq. 2016;214:7–18. doi:10.1016/j.molliq.2015.11.050
   Web of Science ®Google Scholar
• Singh Y, Meher JG, Raval K, et al. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017;252:28–49. doi:10.1016/j.jconrel.2017.03.008
   PubMed Web of Science ®Google Scholar
• Song B, Wu S, Li W, Chen D, Hu H. Folate modified long circulating nano-emulsion as a promising approach for improving the efficiency of chemotherapy drugs in cancer treatment. Pharm Res. 2020;37(12):242. doi:10.1007/s11095-020-02811-1
   PubMed Web of Science ®Google Scholar
• Saani SM, Abdolalizadeh J, Heris SZ. Ultrasonic/sonochemical synthesis and evaluation of nanostructured oil in water emulsions for topical delivery of protein drugs. Ultrason Sonochem. 2019;55:86–95.
   PubMed Web of Science ®Google Scholar
• Masalova I, Tshilumbu NN, Mamedov E, Sanatkaran N. Effect of oil type on stability of high internal phase water-in-oil emulsions with super-cooled internal phase. Chem Eng Commun. 2018;205(1):1–11. doi:10.1080/00986445.2017.1367669
   Web of Science ®Google Scholar
• Gomes A, Costa ALR, Cunha RL. Impact of oil type and WPI/Tween 80 ratio at the oil-water interface: adsorption, interfacial rheology and emulsion features. Colloids Surf B Biointerfaces. 2018;164:272–280. doi:10.1016/j.colsurfb.2018.01.032
   PubMed Web of Science ®Google Scholar
• Izgelov D, Shmoeli E, Domb AJ, Hoffman A. The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats. Int J Pharm. 2020;580:119201. doi:10.1016/j.ijpharm.2020.119201
   PubMed Web of Science ®Google Scholar
• Reddy MR, Gubbiyappa KS. Formulation development, optimization and characterization of Pemigatinib-loaded supersaturable self-nanoemulsifying drug delivery systems. Futur J Pharm Sci. 2022;8(1):45. doi:10.1186/s43094-022-00434-4
   Web of Science ®Google Scholar
• Lee Y, Lee D, Park E, et al. Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy. J Nanobiotechnology. 2021;19(1):411. doi:10.1186/s12951-021-01160-4
   PubMed Web of Science ®Google Scholar
• Handa M, Ujjwal RR, Vasdev N, Flora SJS, Shukla R. Optimization of surfactant-and cosurfactant-aided pine oil nanoemulsions by isothermal low-energy methods for anticholinesterase activity. ACS omega. 2020;6(1):559–568.
   PubMed Web of Science ®Google Scholar
• Galvão KCS, Vicente AA, Sobral PJA. Development, characterization, and stability of O/W pepper nanoemulsions produced by high-pressure homogenization. Food Bioprocess Technol. 2018;11(2):355–367. doi:10.1007/s11947-017-2016-y
   Web of Science ®Google Scholar
• Kumar M, Bishnoi RS, Shukla AK, Jain CP. Techniques for formulation of nanoemulsion drug delivery system: a review. Prev Nutr Food Sci. 2019;24(3):225.
   PubMedGoogle Scholar
• Heidari F, Jafari SM, Ziaiifar AM, Malekjani N. Stability and release mechanisms of double emulsions loaded with bioactive compounds; a critical review. Adv Colloid Interface Sci. 2022;299:102567. doi:10.1016/j.cis.2021.102567
   PubMed Web of Science ®Google Scholar
• Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3(3):145–150. doi:10.1038/nnano.2008.30
   PubMed Web of Science ®Google Scholar
• Manzanares D, Ceña V. Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell. Pharmaceutics. 2020;12(4). doi:10.3390/pharmaceutics12040371
   PubMed Web of Science ®Google Scholar
• Foroozandeh P, Aziz AA. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett. 2018;13. doi:10.1186/s11671-018-2728-6
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2). doi:10.3390/pharmaceutics10020057
   PubMed Web of Science ®Google Scholar
• Nandhakumar S, Dhanaraju MD, Sundar VD, Heera B. Influence of surface charge on the in vitro protein adsorption and cell cytotoxicity of paclitaxel loaded poly(ε-caprolactone) nanoparticles. Bull Fac Pharm Cairo Univ. 2017;55(2):249–258. doi:10.1016/j.bfopcu.2017.06.003
   Google Scholar
• Ghobrial J, Gibson CM, Pinto DS. Delayed clopidogrel transit during myocardial infarction evident on angiography. J Invasive Cardiol. 2015;27(5):E68–9.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhu W, Liu H, Deng F, Wang W, Qin L. Preparation of injectable clopidogrel loaded submicron emulsion for enhancing physicochemical stability and anti-thrombotic efficacy. Int J Pharm. 2022;611:121323. doi:10.1016/j.ijpharm.2021.121323
   PubMedGoogle Scholar
• Abd-Elhakeem E, Teaima MHM, Abdelbary GA, El Mahrouk GM. Bioavailability enhanced clopidogrel-loaded solid SNEDDS: development and in-vitro/in-vivo characterization. J Drug Deliv Sci Technol. 2019;49:603–614.
   Web of Science ®Google Scholar
• Jadvar H. Targeted radionuclide therapy: an evolution toward precision cancer treatment. Am J Roentgenol. 2017;209(2):277–288. doi:10.2214/AJR.17.18264
   PubMed Web of Science ®Google Scholar
• Sousa D, Ferreira D, Rodrigues JL, Rodrigues LR. Nanotechnology in targeted drug delivery and therapeutics. In: In: Mohapatra SS, Ranjan S, Dasgupta N, Mishra RK, editors. Micro and Nano Technologies. Elsevier; 2019:357–409.
   Google Scholar
• Umeda I, Hamamichi S, Fujii H. High tumor accumulation and rapid background clearance by using radionuclide-carrying liposomes for targeted radionuclide therapy and theranostics. J Nucl Med. 2017;58(supplement 1):458458.
   Google Scholar
• Zhao L, Zhu M, Li Y, Xing Y, Zhao J. Radiolabeled dendrimers for nuclear medicine applications. Molecules. 2017;22(9):1350. doi:10.3390/molecules22091350
   PubMed Web of Science ®Google Scholar
• Ognjanović M, Radović M, Mirković M, et al. 99mTc-, 90Y-, and 177Lu-labeled iron oxide nanoflowers designed for potential use in dual magnetic hyperthermia/radionuclide cancer therapy and diagnosis. ACS Appl Mater Interfaces. 2019;11(44):41109–41117. doi:10.1021/acsami.9b16428
   PubMed Web of Science ®Google Scholar
• Ngwa W, Kumar R, Sridhar S, et al. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine. 2014;9(7):1063–1082. doi:10.2217/nnm.14.55
   PubMed Web of Science ®Google Scholar
• Suhail N, Alzahrani AK, Basha WJ, et al. Microemulsions: unique properties, pharmacological applications, and targeted drug delivery. Front Nanotechnol. 2021;2021:3.
   Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• J-g L, Wang A-Y, Wei -Y-Y, Lui W-Y, Chi C-W, Chan W-K. Preparation of [131I]lipiodol as a hepatoma therapeutic agent. Int J Radiat Appl Instrumentation Part a Appl Radiat Isot. 1992;43(12):1431–1435. doi:10.1016/0883-2889(92)90168-E
   PubMedGoogle Scholar
• Park C, Choi SI, Kim H, Yoo HS, Lee YB. Distribution of Lipiodol in hepatocellular carcinoma. Liver. 1990;10(2):72–78. doi:10.1111/j.1600-0676.1990.tb00439.x
   PubMedGoogle Scholar
• Raoul J, Guyader D, Bretagne J, et al. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled–iodized oil in the treatment of hepatocellular carcinoma. Hepatology. 1997;26(5):1156–1161. doi:10.1002/hep.510260511
   PubMed Web of Science ®Google Scholar
• Raoul JL, Bourguet P, Bretagne JF, et al. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology. 1988;168(2):541–545. doi:10.1148/radiology.168.2.2839866
   PubMed Web of Science ®Google Scholar
• Jouneau S, Vauléon E, Caulet-Maugendre S, et al. 131I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases. Chest. 2011;139(6):1463–1469. doi:10.1378/chest.10-1591
   PubMed Web of Science ®Google Scholar
• de Baere T, Zhang X, Aubert B, et al. Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study. Radiology. 1996;201(3):731–735. doi:10.1148/radiology.201.3.8939223
   PubMed Web of Science ®Google Scholar
• Garin E, Denizot B, Roux J, et al. Effect of stabilized iodized oil emulsion on experimentally induced hepatocellular carcinoma in rats. J Vasc Interv Radiol. 2005;16(6):841–848. doi:10.1097/01.RVI.0000156192.89569.0C
   PubMed Web of Science ®Google Scholar
• Shih YH, Lin XZ, Yeh CH, et al. Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma. Int J Nanomedicine. 2014;9:4191–4201. doi:10.2147/IJN.S66346
   PubMed Web of Science ®Google Scholar
• Luo T-Y, Shih Y-H, Chen C-Y, et al. Evaluating the potential of 188Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment. Cancer Biother Radiopharm. 2009;24(5):535–541. doi:10.1089/cbr.2008.0603
   PubMed Web of Science ®Google Scholar
• Kitson LS, Cuccurullo V, Moody ST, Mansi L. Radionuclide antibody-conjugates, a targeted therapy towards cancer. Curr Radiopharm. 2013;6(2):57–71. doi:10.2174/1874471011306020001
   PubMedGoogle Scholar
• Grieve ML, Paterson BM. The evolving coordination chemistry of radiometals for targeted alpha therapy. Aust J Chem. 2022;75(2):65–88. doi:10.1071/CH21184
   Web of Science ®Google Scholar
• Silindir-Gunay M, Karpuz M, Ozer AY. Targeted alpha therapy and nanocarrier approach. Cancer Biother Radiopharm. 2020;35(6):446–458. doi:10.1089/cbr.2019.3213
   PubMed Web of Science ®Google Scholar
• Du Y, Cortez A, Josefsson A, et al. Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma. PLoS One. 2022;17(1):e0261982. doi:10.1371/journal.pone.0261982
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kai T, Ishida E, Kawashita M, Hiraoka M. Fabrication of yttria microcapsules for radiotherapy from water/oil emulsion. J Ceram Soc Japan. 2010;118(1378):479–482. doi:10.2109/jcersj2.118.479
   Web of Science ®Google Scholar
• Kawashita M, Takayama Y, Kokubo T, Takaoka GH, Araki N, Hiraoka M. Enzymatic preparation of hollow yttrium oxide microspheres for in situ radiotherapy of deep-seated cancer. J Am Ceram Soc. 2006;89(4):1347–1351. doi:10.1111/j.1551-2916.2005.00867.x
   Web of Science ®Google Scholar
• Memon K, Lewandowski RJ, Riaz A, Salem R. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma. In: Vauthey JN, Brouquet A, editors. Multidisciplinary Treatment of Hepatocellular Carcinoma. Berlin Heidelberg: Springer; 2013:207–224.
   Google Scholar
• Park YN, Yang C-P, Fernandez GJ, Cubukcu O, Thung SN, Theise ND. Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol. 1998;22(6):1.
   PubMed Web of Science ®Google Scholar
• Padia SA, Shivaram G, Bastawrous S, et al. Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. J Vasc Interv Radiol. 2013;24(3):301–306. doi:10.1016/j.jvir.2012.11.023
   PubMed Web of Science ®Google Scholar
• Sridharan DM, Asaithamby A, Bailey SM, et al. Understanding cancer development processes after HZE-Particle exposure: roles of ROS, DNA damage repair and inflammation. Radiat Res. 2015;183(1):1–26. doi:10.1667/RR13804.1
   PubMed Web of Science ®Google Scholar
• Brown JM. The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain memorial award lecture. Cancer Res. 1999;59(23):5863–5870.
   PubMed Web of Science ®Google Scholar
• Marie-Egyptienne DT, Lohse I, Hill RP. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia. Cancer Lett. 2013;341(1):63–72. doi:10.1016/j.canlet.2012.11.019
   PubMed Web of Science ®Google Scholar
• Peitzsch C, Perrin R, Hill RP, Dubrovska A, Kurth I. Hypoxia as a biomarker for radioresistant cancer stem cells. Int J Radiat Biol. 2014;90(8):636–652. doi:10.3109/09553002.2014.916841
   PubMed Web of Science ®Google Scholar
• Wang H, Mu X, He H, Zhang X-D. Cancer radiosensitizers. Trends Pharmacol Sci. 2018;39(1):24–48. doi:10.1016/j.tips.2017.11.003
   PubMed Web of Science ®Google Scholar
• Krafft MP. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv Drug Deliv Rev. 2001;47(2):209–228. doi:10.1016/S0169-409X(01)00107-7
   PubMed Web of Science ®Google Scholar
• Johnson JLH, Dolezal MC, Kerschen A, Matsunaga TO, Unger EC. In vitro comparison of Dodecafluoropentane (DDFP), Perfluorodecalin (PFD), and Perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif Cells Blood Sub Biotechnol. 2009;37(4):156–162. doi:10.1080/10731190903043192
   PubMed Web of Science ®Google Scholar
• Suyama T, Yokoyama K, Naito R. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients. Prog Clin Biol Res. 1981;55:609–628.
   PubMedGoogle Scholar
• Rockwell S, Irvin CG, Kelley M, et al. Effects of hyperbaric oxygen and a perfluorooctylbromide emulsion on the radiation responses of tumors and normal tissues in rodents. Int J Radiat Oncol. 1992;22(1):87–93. doi:10.1016/0360-3016(92)90986-R
   PubMed Web of Science ®Google Scholar
• Evans RG, Kimler BF, Morantz RA, et al. A phase I/II study of the use of Fluosol® as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors. Int J Radiat Oncol. 1990;19(2):415–420. doi:10.1016/0360-3016(90)90551-T
   PubMed Web of Science ®Google Scholar
• Police AM, Waxman K, Tominaga G. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss. Crit Care Med. 1985;13(2):1.
   PubMed Web of Science ®Google Scholar
• Johnson JLH, Leos RA, Baker AF, Unger EC. Radiosensitization of Hs-766T pancreatic tumor xenografts in mice dosed with dodecafluoropentane nano-emulsion-preliminary findings. J Biomed Nanotechnol. 2015;11(2):274–281. doi:10.1166/jbn.2015.1903
   PubMed Web of Science ®Google Scholar
• Jayaraman MS, Graham K, Unger EC. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe). Artif Cells Nanomed Biotechnol. 2019;47(1):783–789. doi:10.1080/21691401.2019.1577882
   PubMed Web of Science ®Google Scholar
• Johnson JLH. Oxygen carriers: are they enough for cellular support? In: Lapchak PA, Zhang JH, editors. Neuroprotective Therapy for Stroke and Ischemic Disease. Springer International Publishing; 2017:621–640.
   Google Scholar
• Correas J-M, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med Biol. 2001;27(4):565–570. doi:10.1016/s0301-5629(00)00363-x
   PubMed Web of Science ®Google Scholar
• Graham K, Unger E. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Int J Nanomedicine. 2018;13:6049–6058. doi:10.2147/IJN.S140462
   PubMed Web of Science ®Google Scholar
• Komatsu H, Kandeel F, Mullen Y. Impact of oxygen on pancreatic islet survival. Pancreas. 2018;47(5):533–543. doi:10.1097/MPA.0000000000001050
   PubMed Web of Science ®Google Scholar
• Jalani G, Jeyachandran D, Bertram Church R, Cerruti M. Graphene oxide-stabilized perfluorocarbon emulsions for controlled oxygen delivery. Nanoscale. 2017;9(29):10161–10166. doi:10.1039/C7NR00378A
   PubMed Web of Science ®Google Scholar
• Fu X, Ohta S, Kamihira M, Sakai Y, Ito T. Size-controlled preparation of microsized perfluorocarbon emulsions as oxygen carriers via the shirasu porous glass membrane emulsification technique. Langmuir. 2019;35(11):4094–4100. doi:10.1021/acs.langmuir.9b00194
   PubMed Web of Science ®Google Scholar
• Fu X, Ohta S, Kawakatsu T, Kamihira M, Sakai Y, Ito T. Bioinspired perfluorocarbon-based oxygen carriers with concave shape and deformable shell. Adv Mater Technol. 2022;7(3):2100573. doi:10.1002/admt.202100573
   Web of Science ®Google Scholar
• Kaoui B, Biros G, Misbah C. Why do red blood cells have asymmetric shapes even in a symmetric flow? Phys Rev Lett. 2009;103(18):188101. doi:10.1103/PhysRevLett.103.188101
   PubMed Web of Science ®Google Scholar
• Hein AL, Ouellette MM, Yan Y. Radiation-induced signaling pathways that promote cancer cell survival (review). Int J Oncol. 2014;45(5):1813–1819. doi:10.3892/ijo.2014.2614
   PubMed Web of Science ®Google Scholar
• Mansouri K, Rasoulpoor S, Daneshkhah A, et al. Clinical effects of curcumin in enhancing cancer therapy: a systematic review. BMC Cancer. 2020;20(1):791. doi:10.1186/s12885-020-07256-8
   PubMed Web of Science ®Google Scholar
• Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene. 2004;23(8):1599–1607. doi:10.1038/sj.onc.1207284
   PubMed Web of Science ®Google Scholar
• Amekyeh H, Alkhader E, Sabra R, Billa N. Prospects of curcumin nanoformulations in cancer management. Molecules. 2022;27(2). doi:10.3390/molecules27020361
   PubMed Web of Science ®Google Scholar
• Jiang T, Liao W, Charcosset C. Recent advances in encapsulation of curcumin in nanoemulsions: a review of encapsulation technologies, bioaccessibility and applications. Food Res Int. 2020;132:109035. doi:10.1016/j.foodres.2020.109035
   PubMed Web of Science ®Google Scholar
• Minafra L, Porcino N, Bravatà V, et al. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. Sci Rep. 2019;9(1):11134. doi:10.1038/s41598-019-47553-2
   PubMed Web of Science ®Google Scholar
• Lundsten S, Spiegelberg D, Raval NR, Nestor M. The radiosensitizer Onalespib increases complete remission in (177)Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts. Eur J Nucl Med Mol Imaging. 2020;47(4):980–990. doi:10.1007/s00259-019-04673-1
   PubMed Web of Science ®Google Scholar
• Tian M, He X, Jin C, et al. Transpathology: molecular imaging-based pathology. Eur J Nucl Med Mol Imaging. 2021;48(8):2338–2350. doi:10.1007/s00259-021-05234-1
   PubMed Web of Science ®Google Scholar
• Carrete LR, Young JS, Cha S. Advanced imaging techniques for newly diagnosed and recurrent gliomas. Front Neurosci. 2022;16:1.
   Web of Science ®Google Scholar
• Israel O, Pellet O, Biassoni L, et al. Two decades of SPECT/CT – the coming of age of a technology: an updated review of literature evidence. Eur J Nucl Med Mol Imaging. 2019;46(10):1990–2012. doi:10.1007/s00259-019-04404-6
   PubMed Web of Science ®Google Scholar
• Vaquero JJ, Kinahan P. Positron emission tomography: current challenges and opportunities for technological advances in clinical and preclinical imaging systems. Annu Rev Biomed Eng. 2015;17:385–414. doi:10.1146/annurev-bioeng-071114-040723
   PubMed Web of Science ®Google Scholar
• Boschi A, Uccelli L, Marvelli L, Cittanti C, Giganti M, Martini P. Technetium-99m radiopharmaceuticals for ideal myocardial perfusion imaging: lost and found opportunities. Molecules. 2022;27(4). doi:10.3390/molecules27041188
   Web of Science ®Google Scholar
• Liu M, Anderson R-C, Lan X, Conti PS, Chen K. Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer. Med Res Rev. 2020;40(3):909–930. doi:10.1002/med.21642
   PubMed Web of Science ®Google Scholar
• Nagachinta S, Bouzo BL, Vazquez-Rios AJ, Lopez R. Sphingomyelin-Based Nanosystems (SNs) for the development of anticancer miRNA therapeutics. Pharmaceutics. 2020;12(2):189. doi:10.3390/pharmaceutics12020189
   PubMed Web of Science ®Google Scholar
• Takino T, Konishi K, Takakura Y, Hashida M. Long circulating emulsion carrier systems for highly lipophilic drugs. Biol Pharm Bull. 1994;17(1):121–125. doi:10.1248/bpb.17.121
   PubMed Web of Science ®Google Scholar
• Huang G, Huang H. Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system. J Control Release. 2018;278:122–126. doi:10.1016/j.jconrel.2018.04.015
   PubMed Web of Science ®Google Scholar
• Wang C, Leach BI, Lister D, et al. Metallofluorocarbon nanoemulsion for inflammatory macrophage detection via PET and MRI. J Nucl Med. 2021;62(8):1146–1153. doi:10.2967/jnumed.120.255273
   PubMed Web of Science ®Google Scholar
• Klang V, Matsko NB, Valenta C, Hofer F. Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment. Micron. 2012;43(2–3):85–103. doi:10.1016/j.micron.2011.07.014
   PubMed Web of Science ®Google Scholar